ABUS vs AEP · P/E 5.4, rev $6.2M vs P/E 19, rev $21.88B
Arbutus Biopharma Corp (ABUS) versus American Electric Power Co Inc (AEP) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
American Electric Power Co Inc (AEP) is a utilities - regulated electric company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported AEP revenue for 2025-12-31 was $21.88B. Net income was $3.70B. Revenue was up 9.5% from 2024-12-31 to 2025-12-31. AEP currently screens at market cap $69.79B and trailing P/E 19.0.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. AEP currently screens at market cap $69.79B and trailing P/E 19.0.
Not investment advice. Open the ABUS and AEP stock pages for the full models.
Not investment advice.